Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Cardiac Rhythm Management (CRM) Devices And Equipment Market Expansion Outlook: What Revenue Opportunities Are Ahead?
The market for cardiac rhythm management (crm) devices and equipment has seen rapid expansion in recent years. It is anticipated to increase from $15.52 billion in 2025 to $17.07 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.0%. The historical expansion can be ascribed to several factors, including a higher incidence of cardiac arrhythmias, the proliferation of electrophysiology treatment centers, augmented deployment of pacemakers and defibrillators, advancements in device implantation techniques, and increased understanding of sudden cardiac arrest management.
The cardiac rhythm management (crm) devices and equipment market is anticipated to show significant growth over the next few years. It is expected to expand to $21.22 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 5.6%. The expansion during this forecast period can be attributed to several factors including increasing demand for home-based cardiac monitoring, the rising adoption of leadless pacemakers, the enlargement of heart failure management programs, growing investments in smart CRM platforms, and continuous innovation in low-power device electronics. Key trends in the upcoming period are set to include the increasing adoption of remote cardiac monitoring devices, the rising use of miniaturized implantable CRM devices, the growing integration of AI-based arrhythmia detection, the expansion of wireless and leadless technologies, and an enhanced focus on battery longevity and device safety.
Get A Free Sample Report With In-Depth Market Insights:
Cardiac Rhythm Management (CRM) Devices And Equipment Market Growth Factors: What’s Supporting Expansion?
The expanding demographic of individuals aged 65 and above, known as the geriatric population, is anticipated to boost the cardiac rhythm management (CRM) devices and equipment market. As this demographic grows, there’s a corresponding increase in cardiovascular disease prevalence, thereby escalating the need for CRM devices. Such devices are crucial for managing heart rhythm irregularities like arrhythmias and enhancing the well-being of older adults. For illustration, data from the Administration for Community Living, a US government body, indicates that the elderly demographic is projected to reach 80.8 million by 2040 and 94.7 million by 2060. Consequently, the rising geriatric population is a key factor propelling the expansion of the cardiac rhythm management (CRM) devices and equipment market. The growing prevalence of cardiovascular diseases is anticipated to accelerate the expansion of the cardiac rhythm management (CRM) devices and equipment market. Cardiovascular diseases encompass various conditions impacting the heart and blood vessels, such as coronary artery disease, heart attacks, strokes, hypertension, heart failure, and arrhythmias. Unhealthy lifestyle choices, including poor diets and insufficient physical activity, significantly contribute to this rise. Cardiac Rhythm Management (CRM) devices and equipment play a vital role in the diagnosis, oversight, and treatment of these diseases, especially those involving abnormal heart rhythms. For example, the American Heart Association, a US non-profit, reported in January 2024 that the age-adjusted death rate from cardiovascular disease climbed to 233.3 per 100,000 in 2024, marking a 4.0% increase from 224.4 per 100,000 in 2023. Consequently, the increasing rates of cardiovascular diseases are a primary catalyst for the growth of the cardiac rhythm management (CRM) devices and equipment market.
Cardiac Rhythm Management (CRM) Devices And Equipment Market Segment Landscape And Growth Outlook
The cardiac rhythm management (crm) devices and equipment market covered in this report is segmented –
1) By Product: Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT)
2) By Application: Bradycardia, Tachycardia, Heart Failure, Other Applications
3) By End User: Hospitals, Ambulatory Surgical Centers, Physicians Clinics
Subsegments:
1) By Pacemakers: Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers, Implantable Pacemakers
2) By Defibrillators: Implantable Cardioverter Defibrillators (ICDs), External Defibrillators, Wearable Defibrillators, Automated External Defibrillators (AEDs)
3) By Cardiac Resynchronization Therapy (CRT): CRT-P (Pacemaker), CRT-D (Defibrillator), Bi-Ventricular Pacemakers
Cardiac Rhythm Management (CRM) Devices And Equipment Market Industry Trends: What’s Reshaping Demand?
Leading companies within the cardiac rhythm management (CRM) devices and equipment market are concentrating on creating leadless and advanced miniature pacemakers, including dual-chamber leadless systems, with the goal of minimizing lead-related complications, increasing patient eligibility, and boosting long-term therapy durability. A dual-chamber/leadless pacemaker system is an implantable pacing solution that delivers atrial and ventricular pacing without transvenous leads. This is achieved using either two small, self-contained implants that communicate or a single miniaturized device with sophisticated sensing, thereby reducing infection and lead-failure risks while maintaining physiological pacing. For instance, in July 2023, Abbott, a US-based medical device company, initiated commercial implants of the AVEIR DR dual-chamber leadless pacemaker system after receiving FDA approval earlier that year, presenting the first leadless alternative to treat both atrial and ventricular pacing indications and enabling implant-to-implant communication for synchronized dual-chamber therapy.
Cardiac Rhythm Management (CRM) Devices And Equipment Market Leading Companies And Competitive Benchmarking
Major companies operating in the cardiac rhythm management (crm) devices and equipment market are Abbott Laboratories, Medtronic plc, Biotronik SE & Co. KG, Cardiac Science Corporation, Schiller AG, Integer Holdings, Philips Healthcare, Röchling Medical, CCC Medical Devices, LivaNova plc, ZOLL Medical Corporation, Koninklijke Philips N.V., Applied Cardiac Systems, MicroPort Scientific Corporation, ReliantHeart Inc., Shree Pacetronix Ltd., Shaanxi Qinming Medical Instrument Co. Ltd., Boston Scientific Corporation, Progetti Srl, Medico S.p.A.
View The Full Cardiac Rhythm Management (CRM) Devices And Equipment Market Report:
Cardiac Rhythm Management (CRM) Devices And Equipment Market Top Region By Revenue And Market Share
North America was the largest region in the global cardiac rhythm management (CRM) devices and equipment market in 2025. Western Europe was the second-largest region in the cardiac rhythm management (CRM) devices and equipment market. The regions covered in the cardiac rhythm management (crm) devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
